Science-driven innovation backed by rigorous quality assurance — the foundation of every product we create.
At Devino Blu, research is not an afterthought — it is the heartbeat of our organisation. Our dedicated R&D team works in modern laboratory facilities equipped with analytical instruments that meet international standards.
From preformulation studies and excipient selection to clinical-grade stability testing and scale-up trials, every formulation undergoes a thorough development journey before it reaches our manufacturing floor.
We invest significantly in exploring novel drug delivery systems, extended-release technologies, and therapeutic combinations — ensuring our pipeline stays ahead of evolving clinical needs.
Quality is not something we check at the end of production — it is built into every step of our process. Our Quality Assurance (QA) and Quality Control (QC) systems are designed to prevent deviations before they occur.
Every incoming raw material and excipient is tested for identity, purity, potency, and microbial quality before use.
Continuous monitoring of critical process parameters during manufacturing to ensure batch-to-batch consistency.
Comprehensive analytical testing of finished products against IP/BP/USP specifications before market release.
Real-time and accelerated stability studies conducted under ICH-compliant climatic chambers to validate shelf life.
Devino Blu adheres to and holds certifications from the most respected regulatory and quality bodies.
World Health Organisation Good Manufacturing Practice certified facility
Quality Management System certification for consistent, high-quality processes
Tamil Nadu State Drug Controller approved manufacturing and wholesale licence
Food Safety and Standards Authority of India licence for nutraceutical products
Our innovation agenda is focused on three key frontiers: novel drug delivery systems, combination therapies for chronic diseases, and nutraceutical-pharmaceutical convergence products.
We are actively developing modified-release formulations, transdermal systems, and fast-dissolving dosage forms that improve patient compliance and therapeutic outcomes. Our pipeline includes 12+ new molecules and formulations currently under various stages of development.
Devino Blu also invests in digital quality systems — incorporating electronic batch records (eBR), LIMS (Laboratory Information Management Systems), and real-time environmental monitoring to stay at the forefront of smart pharmaceutical manufacturing.
Extended and controlled-release oral dosage forms for improved efficacy and reduced dosing frequency.
Fixed-dose combinations addressing multi-morbidity in hypertension, diabetes, and respiratory conditions.
Science-backed nutraceuticals bridging the gap between preventive nutrition and therapeutic medicine.
A glimpse into our state-of-the-art research and manufacturing facilities.